TrialBlood2017
Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy.
Eric J Duncavage et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papercites it